Is the Recipient forbidden from any effort to discover the identity of anonymized subjects from Clinical Data and DNA received from the NCGS?
Related Questions
- What assurance to the investigator and their subjects is there that NIDA will handle the clinical data and biological materials (DNA) as indicated in the data-sharing plan?
- Is the Recipient forbidden from any effort to discover the identity of anonymized subjects from Clinical Data and DNA received from the NCGS?
- When must the Recipient destroy Biomaterials, Clinical Data, and Genetic Analysis Data received from the NCGS?